Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Terazosin and finasteride together cause no major issues.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Tofacitinib is effective and safe for treating severe alopecia areata.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

CTP-543 is generally safe for treating alopecia areata.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Tofacitinib may effectively treat folliculitis decalvans.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.